Chiesi USA Announces Publication of Health Economics Analysis of Selective Early Rescue Surfactant Administration vs. Standard Surfactant Administration for Premature Infants with Respiratory Distress Syndrome

This cost-consequence analysis suggests selective early rescue surfactant administration strategies are associated with a lower healthcare burden in premature infants with RDS.

Related Keywords

United States ,North Carolina ,United Kingdom ,Italy ,China ,Sweden ,Canada ,France ,Chiesi Farmaceutici ,Marc Claussen ,B Corp ,Chiesi Group ,Chiesi United States Inc ,Health Economic ,Certifiedb Corporation ,Pediatric Pharmacology ,Vice President ,Market Access ,Chiesi United ,Value Information ,Intratracheal Suspension ,Respiratory Distress Syndrome ,Full Prescribing Information ,Benefit Corporation ,Medical Specialties ,Medicine ,Pharmaceuticals ,Rare Diseases ,Syndromes ,Bronchopulmonary Dysplasia ,Infancy ,Infant Respiratory Distress Syndrome ,Intensive Care Medicine ,Neonatology ,Poractant Alfa ,Preterm Birth ,Respiratory Therapy ,